Regal Partners Ltd Purchases 42,148 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Regal Partners Ltd lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 15.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 311,648 shares of the company’s stock after acquiring an additional 42,148 shares during the quarter. GE HealthCare Technologies makes up 2.5% of Regal Partners Ltd’s investment portfolio, making the stock its 14th largest position. Regal Partners Ltd’s holdings in GE HealthCare Technologies were worth $24,365,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in GEHC. Utah Retirement Systems boosted its holdings in shares of GE HealthCare Technologies by 3.3% in the fourth quarter. Utah Retirement Systems now owns 75,465 shares of the company’s stock worth $5,900,000 after acquiring an additional 2,400 shares during the period. AQR Capital Management LLC lifted its holdings in GE HealthCare Technologies by 13.6% during the 4th quarter. AQR Capital Management LLC now owns 237,322 shares of the company’s stock worth $18,554,000 after purchasing an additional 28,445 shares in the last quarter. Lido Advisors LLC boosted its stake in GE HealthCare Technologies by 9.8% in the 4th quarter. Lido Advisors LLC now owns 10,801 shares of the company’s stock worth $844,000 after purchasing an additional 967 shares during the period. Northern Trust Corp grew its holdings in GE HealthCare Technologies by 13.6% during the 4th quarter. Northern Trust Corp now owns 4,631,875 shares of the company’s stock valued at $362,120,000 after buying an additional 555,816 shares in the last quarter. Finally, Beacon Pointe Advisors LLC increased its position in shares of GE HealthCare Technologies by 12.8% during the fourth quarter. Beacon Pointe Advisors LLC now owns 13,667 shares of the company’s stock valued at $1,069,000 after buying an additional 1,553 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $68.09 on Wednesday. The company has a market capitalization of $31.17 billion, a price-to-earnings ratio of 15.73, a PEG ratio of 3.19 and a beta of 1.14. The business has a 50 day moving average of $75.62 and a 200 day moving average of $81.81. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.21%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.23%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on GEHC shares. BTIG Research set a $95.00 price objective on shares of GE HealthCare Technologies and gave the company a “buy” rating in a research note on Monday, April 14th. Citigroup boosted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $96.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.